ScoreHaematology
CNS-IPI: CNS relapse risk in diffuse large B-cell lymphoma
Estimates the 2-year risk of central nervous system relapse or progression in DLBCL treated with R-CHOP.
Updated 31 October 2026
When to use it
Patients with DLBCL at diagnosis starting R-CHOP or similar, to decide on CNS work-up and prophylaxis.
What it needs
- Age > 60 years
- Serum LDH above the upper limit of normal
- ECOG ≥ 2
- Ann Arbor stage III–IV
- More than 1 extranodal site
- Kidney or adrenal involvement
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 1 | Low risk: 2-year CNS relapse ≈ 0.6% |
| 2–3 | Intermediate risk: 2-year CNS relapse ≈ 3.4% |
| ≥ 4 | High risk: 2-year CNS relapse ≈ 10% |
Practical tip
Nearly 90% of patients fall into low or intermediate risk (< 5%) and can be spared CNS work-up and prophylaxis.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
